show episodes
 
Loading …
show series
 
Ultrasonography in the prediction of gout flares: a 12-month prospective observational study Dr Edoardo Cipolletta (Polytechnic University of Marche, Italy) joins Marwan Bukhari to discuss the March Editor's choice article on ultrasonography in the prediction of gout flares. Here, Dr Cipolletta discusses whether ultrasonography adds to the value of…
 
Effectiveness of the BNT162b2 mRNA COVID-19 vaccine among adolescents with juvenile-onset inflammatory rheumatic diseases (IRDs). Dr Amit Ziv and Prof Yosef Uziel (both Tel Aviv University and Meir Medical Center, Israel) join Dr Herman Tam to discuss the effectiveness of the BNT162b2 mRNA COVID-19 vaccine in preventing infection in adolescents wit…
 
A new autoantibody to valyl transfer RNA synthetase associated with anti-synthetase syndrome Dr Tsuneo Sasai and Dr Ran Nakashima (both Kyoto University Graduate School of Medicine, Japan) join Dr Latika Gupta to discuss a 43-year-old male patient clinically diagnosed with anti-synthetase syndrome but lacking any known disease-specific autoantibodi…
 
Long-term use of glucocorticoids for polymyalgia rheumatica: follow-up of the PMR Cohort study Dr Sara Muller (Keele University, UK) and Prof Samantha Hider (Keele University, UK) join Dr Sheilla Achieng to discuss a follow-up to the PMR cohort study, an inception cohort of 652 patients from English general practices who were diagnosed with PMR bet…
 
Smartphone images of systemic sclerosis-related digital ulcers provide a clear picture of disease progression for the first rheumatology visit. Dr Anastasia Madenidou (University of Manchester, UK ) and Dr Graham Dinsdale (Salford Royal Hospital & University of Manchester, UK) join Dr Latika Gupta to discuss their report of a patient with SSc-relat…
 
In our final episode of 2022, Dr Alla Ishchenko (UZ Leuven, Belgium) joins Dr Latika Gupta to celebrate the achievements of leading women in rheumatology. You can read the full paper here. Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, or tweet us @RheumJnl. Want to read more of …
 
Dr Sarah Bennett (University of Bristol, UK) joins Prof Diederik de Cock to discuss results from the LIFT study – a randomised trial exploring interventions to support people with fatigue. Here, Dr Bennett talks us through the experiences of both the health professionals delivering these interventions and the patients receiving them. You can read m…
 
BSR has published two updated guidelines with recommendations for using rheumatological drugs during conception, all stages of pregnancy, breastfeeding and in men who wish to conceive. The guidelines have been split into two parts covering: prescribing medications to treat co-morbidities in rheumatic diseases during pregnancy and breastfeeding pres…
 
Dr Sarah Khidir and Dr Elise van Mulligen (Leiden UMC, the Netherlands) join Dr Pankti Mehta to discuss the link between educational attainment and clinically suspect arthralgia. Using data from two cohorts, they identified an association between low educational attainment and increased risk of progression from arthralgia to inflammatory arthritis.…
 
Dr Ai Lyn Tan speaks to Dr James Gwinnutt (University of Manchester, UK) about cognitive impairment in people with rheumatoid arthritis. Read the paper here: https://doi.org/10.1093/rap/rkab044 Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, or tweet us @RheumJnl. Want to read mor…
 
Dr Chris Wincup and Dr Marta Alarcón-Riquelme (GENYO, Spain) discuss the use of precision medicine in autoimmune diseases. Find the paper here: https://doi.org/10.1093/rheumatology/keab448 Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, or tweet us @RheumJnl. Want to read more of …
 
On today's episode, Dr Giovanni Adami (Verona, Italy) joins Dr Marwan Bukhari to discuss the association between environmental air pollution and rheumatoid arthritis flares. Read the paper here: https://doi.org/10.1093/rheumatology/keab049 Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumRes…
 
Dr Marwan Bukhari (Royal Lancaster Infirmary, UK) and Prof. Maarten Boers (Amsterdam UMC, The Netherlands) join Dr Ai Lyn Tan to discuss the effects of glucocorticoids on bone health. Their observational data suggest that glucocorticoids do not have the detrimental impact on bone health that we have come to expect – a rather controversial finding i…
 
The team from Chapel Allerton Hospital (Leeds, UK) join us to discuss their new giant cell arteritis referral pathway, which recently won a BSR Best Practice Award. Listen to Dr Thurkka Rajeswaran, Dr Sarah Mackie, Kate Smith and Borsha Sarker as they present their GCA pathway and results, reflect on MDT collaboration and advice for other units, an…
 
We’re joined by Dr Anushka Soni, Sarah Manderson and Prof. Raashid Luqmani (Nuffield Orthopaedic Centre, Oxford) to discuss their remote clinical management pathway, which recently won a BSR Best Practice Award. The team talk us through their pathway, cost-savings, and the essential role of their admin team, before revealing their PIFU plans. You c…
 
Dr Toby Garrood (Guy’s & St Thomas’, UK) joins us to discuss a three-part project to implement digital health in rheumatology, which recently won a BSR Best Practice Award. Toby talks us through the project, the process of developing patient personas to help test interventions, the benefits of a minimum viable product approach, and much more.…
 
Prof Richard Furie (New York, USA) and Dr Anastasia Madenidou evaluate the Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus. They discuss the unique dose-response relationship endpoint used in this trial and the plans for Phase 3. Read the paper here Thanks …
 
Dr Rishi Desai (Boston, USA) and Dr Marwan Bukhari discuss the risk of venous thromboembolism associated with tofacitinib in rheumatoid arthritis. Dr Desai’s recent paper used claims data to compare the risk of VTE with tofacitinib vs. TNFis. Read the paper here Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter…
 
Dr Lihi Eder (Toronto, Canada) joins Dr Steven Zhao to discuss ultrasound imaging sub-phenotypes in psoriatic arthritis. They discuss clinical vs. imaging clusters of PsA manifestations, the possibility of coagulation and platelet pathway mediation of imaging phenotypes, and more. Read the paper here Thanks for listening to Talking Rheumatology Res…
 
Today's podcast guest is Dr Lucy Carter (Leeds, UK), who joins Dr Chris Wincup to talk about the Easy-BILAG - a comprehensive but simplified version of the BILAG-2004 index for scoring SLE disease activity. They discuss the user-friendly design, training requirements, use with newly approved drugs, and more. Read the paper here: https://doi.org/10.…
 
Dr Peter Grayson (NIH, Bethesda, USA) joins Dr Puja Mehta to discuss VEXAS syndrome. They cover the discovery of VEXAS, how to spot the syndrome in patients, the importance of cross-specialty working, and more. Dr Grayson’s NEJM paper can be found here: https://www.nejm.org/doi/10.1056/NEJMoa2026834 This episode was originally published in May 2021…
 
Prof Christopher Sjöwall (Linköping, Sweden) and Dr Anastastia Madenidou discuss de novo lupus nephritis during treatment with belimumab. They cover the process of collecting observational data, the approval of belimumab for use in lupus nephritis, and implications for clinical practice. Read the paper here: https://doi.org/10.1093/rheumatology/kea…
 
Dr Mark Russell (King's College London, UK) joins Dr Sean Gill to talk about improving outcomes for patients hospitalised with gout. They identify several strategies to improve practice and highlight key gaps in the literature that could be addressed by future research. Read the paper here: https://doi.org/10.1093/rheumatology/keab539 Thanks for li…
 
Dr David Fajgenbaum (University of Pennsylvania, USA) and Dr Puja Mehta discuss cytokine storm syndromes. They consider the definition of cytokine storms and whether COVID-19 meets these criteria, as well as Dr Fajgenbaum’s research journey, as described in his bestselling memoir, 'Chasing my Cure: A Doctor's Race to Turn Hope Into Action'. Read th…
 
Prof Peter Taylor (Oxford, UK) joins Dr David Liew to discuss results from the PERSIST study, a real-world, observational, prospective cohort study of CT-P13 for treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Read the paper here: https://doi.org/10.1093/rap/rkab026 This episode was originally published in Decembe…
 
The 2022 BSR guideline on the management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy has been published, but what do you need to know? Join Prof Hector Chinoy, Dr Alex Oldroyd, Dr James Lilleker, Dr Liza McCann and Dr Phoebe Rushe in a roundtable discussion hosted by Dr Marwan Bukhari. Read the full guideline …
 
How will patients be affected by the 2022 BSR guideline on the management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy? Join junior doctor and IIM patient Dr Phoebe Rushe, Prof Hector Chinoy, Dr Alex Oldroyd, Dr James Lilleker and Dr Liza McCann in a roundtable discussion hosted by Dr Marwan Bukhari. Read the f…
 
Loading …

Quick Reference Guide

Copyright 2023 | Sitemap | Privacy Policy | Terms of Service